학술논문

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
Document Type
Article
Source
In Biology of Blood and Marrow Transplantation November 2015 21(11):1907-1913
Subject
Language
ISSN
1083-8791